National Cancer Institute's Affordable Cancer Technologies (ACTs) Program.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 41604599.
- Also identified by DOI 10.1200/GO-25-00689.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The National Cancer Institute's Affordable Cancer Technologies (ACTs) Program marks a decade of success in supporting translational research. This initiative focuses on delivering affordable, scalable cancer prevention and control solutions for low- and middle-income countries. The program has funded 38 grants resulting in patents, publications, and the adoption of novel approaches, including point-of-care diagnostics for colorectal cancer and HPV, and new technologies for chemotherapy surveillance and cervical precancer treatment. ACTs accelerate life-saving innovations from the lab to real-world communities.
Medical subject headings
- Neoplasms